Abstract
Aims and Objective
To evaluate the role of serum antisperm antibody (ASA) in infertility.
Method and Material
This study was conducted in the Department of Obstetrics and Gynecology, Pt. J.N.M. Medical College, Raipur (C.G.), India, from December 2006 to July 2008 over 105 selected couples with primary and secondary infertility attending the infertility clinic. Their detailed clinical history was taken. Physical examination and routine as well as special investigations like pelvic USG, follicular study, and hysterosalpingography were done in the female. Complete physical examination and semen analysis of male partners were done. Couples were subjected to post coital test (PCT) 2–6 hours after intercourse to rule out cervical factor. Serum ASA titer in both partners was detected by ELISA. Results were interpreted for qualitative evaluation. ASA-positive cases were treated with low-dose daily oral prednisolone for 3 months and evaluated in terms of ASA titer, semen analysis, PCT result, and conception rate. The results were analyzed by statistical methods.
Results
Out of 105 couples, serum ASA-positive males were 38 (39.19%), of which definite serum ASA positive were 9 (8.57%), borderline (equivocal) were 29 (27.61%), and negative were 67 (63.08%). Among females serum ASA positive were 42 (40%), in which definite ASA positive were 19 (18.09%), borderline 23 (21.9%), and negative 63 (60%). Asthenospermia was found more common in ASA-positive men (55.56%, p=0.0001). Poor PCT was most commonly associated in husband ASA negative and wife ASA positive. Treatment with low-dose oral prednisolone resulted in significant increase in motility of sperms in male partners and decrease in ASA titer in both the patients. Pregnancy was achieved in 45.23% ASA-positive females, while among couples with ASA-positive husbands, 31.57% of wives conceived.
Conclusion
Serum ASA are considered to be cause of unexplained infertility and unexplained abnormal PCT. Antibodies against sperm prevent their motility through female reproductive tract and hamper the process of fertilization. Low-dose prednisolone was useful in infertility associated with ASA by improving sperm quality and giving rise to pregnancies.
Similar content being viewed by others
References
Michael CD, Michael CG. The post coital test: a quantitative method. J Androl. 1993; 4: 149–154.
Shibahara Hiroaki, Shiraishi Y, Hirano Y, Suzuki T, Takamizawa S, Suzuki M. Diversity of the inhibitory effects on fertilization by antisperm antibodies bound to the surface f ejaculated human’s sperm. Hum Reprod. 2003; 18(7): 1469–1473.
Krapez JA, Hayden CJ, Rutherford AJ, Balen AH. Survey of the diagnosis and management of antisperm antibodies. Human Reprod. 1998; 13(12): 3363–3367.
Ghazeeri GS, Kutteh WH. Immunological testing and treatment in reproduction: frequency assessment of practice pattern at assisted reproduction clinics in the USA and Australia. Human Reprod. 2001; 16(10): 2130–2135.
Kamleniczna M, Domagata A, Kurpisz M. The frequency of antisperm antibodies in infertile couples - a Polish pilot study. Med Sci Monit. 2003; 9(4): CR. 194–201.
Bubanovic I, Najman S, Kojic S. Immunomodulatory treatment for infertile men with antisperm antibodies. Fertil Steril. 2004; 81: 20.
Guzin Kadir et al. The importance of postcoital test in evaluation of cervical factor. Anatolian J. Gynaecol Obst. 1993; 3: 165–168.
Razzak AH, Wais SA. The infertile couple: a cohort study in Duhok, Iraq. East Mediterr Health J. 2002; 8(2–3): 1.
Lahteenmaki A, Veilahti J, Hovatta O. Intrauterine insemination versus cyclic, low dose predinisolone in couples with male antisperm antibodies. Hum Reprod. 1995: 10(1): 142–147.
Snick HK, Snick TS, Evers JL, Collins JA. The spontaneous pregnancy prognosis in untreated subfertile couples the Walcheren primary care study. Hum Reprod. 1997; 12: 1582–1588.
Hossain A, Islam N, Aryal S, Madanes A. The prevalence of circulating antisperm antibody (ASA) in infertile population representing of all etiologies. Middle East Fertil Soc J. 2007; 12(1): 27–30.
Karimi F, Khazavi S, Alaedini F. Serum antisperm antibodies in fertile and infertile individual. Iran J Med Sci. 2008; 33: 88–93.
Sinha DP, Anderson TD, Halborow EJ, Nandakumar VC. Local immunological factors as a possible cause of reduced sperm motility in the cervical mucus of infertile women. BJOG: An Int J Obstet Gynecol. 2005; 84(12): 948–953.
Ulcova-Gallova Z, Bouse V, Rokyta Z, Krizanovska K, et al. Effect of cortisteroids on sperm antibody concentration in different biological fluid and on pregnancy outcome in immunologic infertility. Originalarbeit Zentralbl Gynakol. 2000: 122(9): 495–499.
Mumuce MJ, Berta CL, Pauluzzi F, Caille AM. Relationship between antisperm antibodies, sperm movement and quality. Urol Int. 2000; 65(4): 200–203.
Alexande E, Omu AE, Al-Qattan F, et al. Effect of low dose continuous corticosteroid therapy in men with antisperm antibodies on spermatozoal quality and conception rate. Eur J Obstet Gynaecol. 1996; 69(2): 129–134.
Philips AS, Ivar F. Does immunity regulate ejaculate quality and fertility in human? Behav Ecol 2004; 16: 410–416.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nagaria, T., Patra, P.K. & Sahu, J.P. Evaluation of serum antisperm antibodies in infertility. J Obstet Gynecol India 61, 307–316 (2011). https://doi.org/10.1007/s13224-011-0034-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13224-011-0034-7